Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

References

• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250–261. doi:10.1016/j.jhep.2019.08.025
   PubMed Web of Science ®Google Scholar
• Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154(6):1706–1718 e1. doi:10.1053/j.gastro.2018.01.064
   PubMed Web of Science ®Google Scholar
• Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it? World J Gastroenterol. 2013;19(47):8808–8821. doi:10.3748/wjg.v19.i47.8808
   PubMed Web of Science ®Google Scholar
• Hassett M, Yopp AC, Singal AG, Palmer BF. Surveillance for hepatocellular carcinoma: how can we do better? Am J Med Sci. 2013;346(4):308–313. doi:10.1097/MAJ.0b013e31828318ff
   PubMed Web of Science ®Google Scholar
• Singal AG, Nehra M, Adams-Huet B, et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol. 2013;108(3):425–432. doi:10.1038/ajg.2012.449
   PubMed Web of Science ®Google Scholar
• Simmons O, Fetzer DT, Yokoo T, et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(1):169–177. doi:10.1111/apt.13841
   PubMed Web of Science ®Google Scholar
• Kim HL, An J, Park JA, Park SH, Lim YS, Lee EK. Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis. Hepatology. 2019;69(4):1599–1613. doi:10.1002/hep.30330
   PubMed Web of Science ®Google Scholar
• Mahmud N, Hoteit MA, Goldberg DS. Risk factors and center-level variation in hepatocellular carcinoma under-staging for liver transplantation. Liver Transpl. 2020;26(8):977–988. doi:10.1002/lt.25787
   PubMed Web of Science ®Google Scholar
• Park PC, Choi GW, M. Zaid M, et al. Enhancement pattern mapping technique for improving contrast-to-noise ratios and detectability of hepatobiliary tumors on multiphase computed tomography. Med Phys. 2020;47(1):64–74. doi:10.1002/mp.13769
   PubMed Web of Science ®Google Scholar
• Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–1128. doi:10.1016/j.neuroimage.2006.01.015
   PubMed Web of Science ®Google Scholar
• Goldberg DS, Taddei TH, Serper M, et al. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Hepatology. 2017;65(3):864–874. doi:10.1002/hep.28765
   PubMed Web of Science ®Google Scholar
• Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289(3):816–830. doi:10.1148/radiol.2018181494
   PubMed Web of Science ®Google Scholar
• Lee YT, Wang JJ, Zhu Y, Agopian VG, Tseng HR, Yang JD. Diagnostic Criteria and LI-RADS for Hepatocellular Carcinoma. Clin Liver Dis. 2021;17(6):409–413. doi:10.1002/cld.1075
   Google Scholar
• Zhang L, Wang JN, Tang JM, et al. VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep. 2012;39(5):5085–5093. doi:10.1007/s11033-011-1304-2
   PubMed Web of Science ®Google Scholar
• Morshid A, Elsayes KM, Khalaf AM, et al. A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiol Artif Intell. 2019;1(5):e180021. doi:10.1148/ryai.2019180021
   PubMedGoogle Scholar
• Yamashita R, Mittendorf A, Zhu Z, et al. Deep convolutional neural network applied to the liver imaging reporting and data system (LI-RADS) version 2014 category classification: a pilot study. Abdom Radiol. 2020;45(1):24–35. doi:10.1007/s00261-019-02306-7
   PubMed Web of Science ®Google Scholar
• Mokrane FZ, Lu L, Vavasseur A, et al. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur Radiol. 2020;30(1):558–570. doi:10.1007/s00330-019-06347-w
   PubMed Web of Science ®Google Scholar
• Wu Y, White GM, Cornelius T, et al. Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors. Ann Transl Med. 2020;8(11):701. doi:10.21037/atm.2019.12.151
   PubMed Web of Science ®Google Scholar
• Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology. 2018;286(3):887–896. doi:10.1148/radiol.2017170706
   PubMed Web of Science ®Google Scholar
• Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol. 2019;29(7):3338–3347. doi:10.1007/s00330-019-06205-9
   PubMed Web of Science ®Google Scholar